- An announcement has just been published 2024-07-12 00:00:00
- 海外监管公告 2024-07-12 00:00:00
- GRANT OF RESTRICTED SHARE UNITSPURSUANT 2024-06-28 00:00:00
- 根据二零二三年股权激励计划授予受限制股份单位 2024-06-28 00:00:00
- An announcement has just been published 2024-06-27 00:00:00
- 海外监管公告 2024-06-27 00:00:00
- POLL RESULTS OF ANNUAL GENERAL MEETINGHE 2024-06-27 00:00:00
- 于二零二四年六月二十七日举行的股东周年大会投票结果 2024-06-27 00:00:00
- 海外监管公告 2024-06-25 00:00:00
- An announcement has just been published 2024-06-25 00:00:00
- 自愿公告 - 国家药品监督管理局受理TAFASITAMAB与来那度胺联合治疗复发 2024-06-20 00:00:00
- VOLUNTARY ANNOUNCEMENT - BIOLOGICS LICEN 2024-06-20 00:00:00
- 自愿公告行政总裁兼执行董事增持本公司股份 2024-05-31 00:00:00
- VOLUNTARY ANNOUNCEMENTINCREASE IN SHAREH 2024-05-31 00:00:00
- An announcement has just been published 2024-05-30 00:00:00
- 海外监管公告 2024-05-30 00:00:00
- 根据二零二三年人民币股份激励计划授予限制性股票 2024-05-30 00:00:00
- GRANT OF RESTRICTED SHARESPURSUANT TO 20 2024-05-30 00:00:00
- 董事会召开日期 2024-04-29 00:00:00
- 股东周年大会通告 2024-04-26 00:00:00
- 建议修订现有组织章程大纲及章程细则之公告 2024-03-28 00:00:00
- 董事会召开日期 2024-03-15 00:00:00
- 根据二零二三年股权激励计划授予受限制股份单位 2023-12-29 00:00:00
- 自愿公告ICP-332治疗特应性皮炎的II期临床研究达到主要终点 2023-12-17 00:00:00
- 董事会召开日期 2023-11-01 00:00:00
- 委任独立非执行董事 2023-10-11 00:00:00
- 自愿公告 场内股份回购 2023-09-08 00:00:00
- 股东特别大会通告 2023-08-15 00:00:00
- 董事会召开日期 2023-08-14 00:00:00
- 暂停办理股份过户登记手续 2023-08-11 00:00:00